NasdaqCM - Nasdaq Real Time Price USD
OncoCyte Corporation (OCX)
2.8900
-0.0600
(-2.03%)
At close: May 6 at 4:00:01 PM EDT
3.0500
+0.16
+(5.54%)
Pre-Market: 7:35:01 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.3M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SMITH PATRICK W. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.05 per share. | Indirect | 2,209,080 | Feb 7, 2025 |
| JAMES ANDREA S. Chief Financial Officer | Purchase at price 2.05 per share. | Direct | 200,000 | Feb 7, 2025 |
| BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.05 per share. | Indirect | 10,589,675 | Feb 6, 2025 |
| SMITH PATRICK W. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.01 - 2.02 per share. | Indirect | 1,839 | Feb 4, 2025 |
| SMITH PATRICK W. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.01 per share. | Indirect | 8,438 | Jan 30, 2025 |
| SMITH PATRICK W. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.08 - 2.15 per share. | Indirect | 34,114 | Jan 14, 2025 |
| ARNO ANDREW Director | Purchase at price 2.11 per share. | Direct | 26,350 | Dec 26, 2024 |
| SMITH PATRICK W. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.13 per share. | Indirect | 192,166 | Dec 26, 2024 |
| JAMES ANDREA S. Chief Financial Officer | Purchase at price 2.29 per share. | Direct | 45,800 | Dec 5, 2024 |
| BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.95 per share. | Indirect | 3,877,619 | Oct 2, 2024 |
| JAMES ANDREA S. Chief Financial Officer | Purchase at price 2.97 per share. | Direct | 100,000 | Oct 2, 2024 |
| BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.92 per share. | Indirect | 7,057,688 | Apr 11, 2024 |
| ARNO ANDREW Director | Purchase at price 2.95 per share. | Direct | 99,999 | Apr 11, 2024 |
| RIGGS JOSHUA Chief Executive Officer | Purchase at price 2.95 per share. | Direct | 10,000 | Apr 11, 2024 |
| KINGSLEY ALFRED D Director | -- | Direct | -- | Jun 23, 2023 |
| ARNO ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 23, 2023 |
| LAST ANDREW J Director | -- | Direct | -- | Jun 23, 2023 |
| SILVERMAN LOUIS E Director | -- | Direct | -- | Jun 23, 2023 |
| KINGSLEY ALFRED D Director | Purchase at price 0.21 per share. | Direct | 6,447 | Jun 14, 2023 |
| PURA VIDA INVESTMENTS L L C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.30 per share. | Indirect | 200,027 | Apr 5, 2023 |
| BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.30 per share. | Indirect | 8,093,898 | Apr 3, 2023 |
| ARNO ANDREW Director | Stock Award(Grant) at price 0.35 per share. | Indirect | 150,001 | Apr 3, 2023 |
| GUTFREUND JOHN PETER Director | Stock Award(Grant) at price 0.35 per share. | Indirect | 604,252 | Apr 3, 2023 |
| ARNO ANDREW Director | Purchase at price 0.35 per share. | Direct | 87,875 | Dec 23, 2022 |
| GUTFREUND JOHN PETER Director | Purchase at price 0.33 per share. | Indirect | 24,728 | Dec 23, 2022 |
| KINGSLEY ALFRED D Director | Purchase at price 0.28 per share. | Direct | 7,125 | Dec 22, 2022 |
| ROSS DOUGLAS T Officer | -- | Direct | -- | Dec 21, 2022 |
| ANDREWS RONALD ASBURY Officer and Director | -- | Direct | -- | Dec 1, 2022 |
| ARNO ANDREW Director | Purchase at price 0.90 per share. | Indirect | 13,500 | Aug 17, 2022 |
| LAST ANDREW J Director | Purchase at price 0.87 per share. | Direct | 17,400 | Aug 17, 2022 |
| GRIFFITH MELINDA Director | Purchase at price 1.00 per share. | Direct | 10,000 | Aug 16, 2022 |
| ARNO ANDREW Director | Purchase at price 0.93 - 0.97 per share. | Direct | 144,121 | Aug 16, 2022 |
| ANDREWS RONALD ASBURY Chief Executive Officer | Purchase at price 0.96 per share. | Direct | 38,400 | Aug 16, 2022 |
| CARTER JENNIFER LEVIN Director | Purchase at price 0.95 per share. | Direct | 9,975 | Aug 16, 2022 |
| GRIFFITH MELINDA Director | -- | Direct | -- | Aug 15, 2022 |
| KINGSLEY ALFRED D Director | -- | Direct | -- | Aug 15, 2022 |
| KINGSLEY ALFRED D Director | Purchase at price 0.97 per share. | Direct | 9,700 | Aug 15, 2022 |
| ARNO ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2022 |
| LAST ANDREW J Director | -- | Direct | -- | Aug 15, 2022 |
| CARTER JENNIFER LEVIN Director | -- | Direct | -- | Aug 15, 2022 |
| ROSS DOUGLAS T Officer | -- | Direct | -- | Aug 15, 2022 |
| PAULSEN GISELA President | -- | Direct | -- | Aug 15, 2022 |
| JOHN ANISH M Chief Financial Officer | -- | Direct | -- | Aug 15, 2022 |
| GUTFREUND JOHN PETER Director | -- | Direct | -- | Aug 15, 2022 |
| GUTFREUND JOHN PETER Director | Purchase at price 0.93 per share. | Indirect | 23,250 | Aug 15, 2022 |
| GRIFFITH MELINDA Director | -- | Direct | -- | Jun 24, 2022 |
| KINGSLEY ALFRED D Director | -- | Direct | -- | Jun 24, 2022 |
| ARNO ANDREW Director | -- | Direct | -- | Jun 24, 2022 |
| REDMOND CAVAN M Director | -- | Direct | -- | Jun 24, 2022 |
| LAST ANDREW J Director | -- | Direct | -- | Jun 24, 2022 |
Related Tickers
XWEL XWELL, Inc.
0.8255
-2.88%
VCYT Veracyte, Inc.
30.56
-2.43%
XGN Exagen Inc.
6.42
+2.72%
ERFSF Eurofins Scientific SE
63.16
0.00%
PRE Prenetics Global Limited
5.23
-0.80%
CHEK Check-Cap Ltd.
1.0300
+16.52%
CSTL Castle Biosciences, Inc.
16.62
-11.36%
NEO NeoGenomics, Inc.
7.69
-1.91%
GH Guardant Health, Inc.
41.93
-4.81%
DGX Quest Diagnostics Incorporated
176.11
-0.82%